推薦產品
生物源
synthetic
化驗
≥99% (HPLC)
形狀
powder
mp
190-193 °C (lit.)
溶解度
water: 50 mg/mL, clear, colorless
儲存溫度
−20°C
SMILES 字串
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(C(=O)NC2=O)C(F)(F)F
InChI
1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1
InChI 密鑰
VSQQQLOSPVPRAZ-RRKCRQDMSA-N
尋找類似的產品? 前往 產品比較指南
應用
三氟胸苷已用作选择性培养基组分,用于筛选淋巴瘤细胞、人淋巴母细胞样细胞TK6和小鼠淋巴瘤细胞L5178Y中的胸苷激酶(TK)突变体。
生化/生理作用
三氟胸苷(TFT)是一种胸苷类似物,对光敏感。TFT可作为胸苷激酶底物,用于研究该酶的特异性和动力学。磷酸化TFT可掺入DNA,诱导DNA损伤,因而TFT适合用于研究DNA修复机制。TFT也可用于研究胸苷酸合成酶抑制机制和筛选胸苷激酶突变基因。它对胃肠道癌具有抗肿瘤活性,也可用于治疗疱疹病毒性角膜炎。
包裝
无底玻璃瓶。内含物在插入的融合锥体内。
訊號詞
Warning
危險聲明
危險分類
Carc. 2 - Muta. 2 - Repr. 2
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
個人防護裝備
dust mask type N95 (US), Eyeshields, Gloves
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
客戶也查看了
International journal of oncology, 39(1), 263-270 (2011-04-15)
Trifluorothymidine (TFT) is well known to be converted to TFT-monophosphate by thymidine kinase and to inhibit thymidylate synthase. In addition, TFT-triphosphate (TFT-TP) is also incorporated into DNA, resulting in cytocidal effects. However, the precise mechanism of TFT-induced DNA damage is
International journal of cancer, 126(10), 2457-2468 (2009-10-10)
Trifluorothymidine (TFT) is part of the oral drug formulation TAS-102. Both 5-fluorouracil (5-FU) and TFT can inhibit thymidylate synthase and be incorporated into DNA. TFT shows only moderate cross-resistance to 5-FU. Therefore, we examined whether mechanistic differences in cell death
Nucleosides, nucleotides & nucleic acids, 27(6), 699-703 (2008-07-05)
Trifluorothymidine (TFT), a potent anticancer agent, inhibits thymidylate synthase (TS) and is incorporated into the DNA, both events resulting in cell death. Cell death induction related to DNA damage often involves activation of p53. We determined the role of p53
Novel cell death mechanisms of trifluorothymidine.
Nucleic Acids Symposium Series, 52, 649-649 (2008)
Drugs, 79(14), 1583-1590 (2019-09-07)
Trifluridine/tipiracil (Lonsurf®) is a fixed-dose combination tablet comprising trifluridine, an antineoplastic nucleoside analogue, and tipiracil, a thymidine phosphorylase inhibitor. Trifluridine/tipiracil has recently been granted an additional indication in the USA for the treatment of metastatic gastric cancer, including gastroesophageal junction
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務